Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Current therapies for adults with anaplastic astrocytoma provide limited benefit
to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may
prove beneficial in the treatment of adults with anaplastic astrocytoma.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on adults with anaplastic astrocytoma.